Sarepta Therapeutics (SRPT) Amortizatization of Intangibles (2014 - 2026)

Sarepta Therapeutics' Amortizatization of Intangibles history runs 9 years deep, the most recent figure standing at -$530000.0 for Q1 2026.

• On a quarterly basis, Amortizatization of Intangibles rose 72.28% year-over-year to -$530000.0 in Q1 2026; TTM through Mar 2026 was -$3.9 million, a 86.88% increase from a year earlier, with the FY2025 full-year figure at -$5.3 million, up 86.86% from the prior year.
• Amortizatization of Intangibles retreated to -$530000.0 in Q1 2026 per SRPT's latest filing, from -$380000.0 in the prior quarter.
• Across five years, Amortizatization of Intangibles topped out at -$50000.0 in Q1 2022 and bottomed at -$13.3 million in Q4 2023.
• The 5-year median for Amortizatization of Intangibles is -$6.1 million (2022), against an average of -$6.1 million.
• Across the five-year window, Amortizatization of Intangibles tumbled 17202.0% in 2023 and soared 94.41% in 2025, its largest moves.
• Year by year, Amortizatization of Intangibles stood at -$6.1 million in 2022, then plunged by 117.33% to -$13.3 million in 2023, then jumped by 48.96% to -$6.8 million in 2024, then surged by 94.41% to -$380000.0 in 2025, then plunged by 39.47% to -$530000.0 in 2026.
• Per Business Quant, the three latest SRPT Amortizatization of Intangibles figures stand at -$530000.0 (Q1 2026), -$380000.0 (Q4 2025), and -$1.1 million (Q3 2025).